Lung Cancer News & Updates
- FDA OKs First-of-Its-Kind Lung Cancer Pill
July 7, 2025 — The FDA has granted quick approval to sunvozertinib (sold as Zegfrovy) a first-of-its-kind pill for a type of lung cancer known as non-small-cell lung cancer (NSCLC).
- FDA OKs New Next-Gen Pill for Rare Lung Cancer
June 12, 2025 — The FDA has approved an oral pill called taletrectinib (Ibtrozi) to treat people who have a rare type of non-small-cell lung cancer (NSCLC) that is linked to a faulty ROS1 gene and has spread or worsened.
- FDA OKs New Treatment for Hard-to-Treat Lung Cancer
May 16, 2025 — The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.
- FDA Approves New Drug for Advanced Lung Cancer
December 19, 2024 — The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC).
- mRNA Lung Cancer Vaccine Could Be Revolutionary Treatment
December 17, 2024 — A new vaccine to treat non-small-cell lung cancer is undergoing phase I trials and offering a potential breakthrough in immunotherapy.
- FDA Approves Drug for Aggressive Small-Cell Lung Cancer
December 9, 2024 — The FDA has approved the drug durvalumab for adults with limited-stage small-cell lung cancer (LS-SCLC) whose disease hasn’t gotten worse after getting platinum-based chemo and radiation at the same time.
- FDA Approves New Treatment for Non-Small-Cell Lung Cancer
August 21, 2024 — Clinical trials showed patients lived longer without disease progression, compared to the standard treatment currently used.
- Lung Cancer Drug’s 'Off-the-Charts’ Results Give Patients Hope
June 6, 2024 — Researchers believe the drug could make certain kinds of lung cancers a chronic disease like diabetes, and not necessarily a death sentence.
- Trend Rolls On: Women at Higher Lung Cancer Risk
October 13, 2023 — Researchers are calling for intensified smoking cessation efforts and lung screenings among young and middle-aged women after a new analysis showed they are increasingly more likely than men to be diagnosed with lung cancer. The trend has been under way in recent years.
- EGFR Lung Cancer in Asian People
July 4, 2023 — EGFR mutation is a type of DNA mistake that causes cancer cells to grow and divide faster, This form of lung cancer largely affects young people and Asian women. Learn more.
- The Case for Lung Cancer Screening
June 14, 2023 — Besides smoking, what defines high risk? And what are the current guidelines for screening?
- Severe Asthma and Lung Cancer: What’s the Link?
May 22, 2023 — Cutting-edge research is highlighting the link between heavily symptomatic asthma and lung cancer. Here's what to know.
- AI Tool Can Detect Early Signs of Lung Cancer, Researchers Say
April 12, 2023 — A new AI tool named Sybil can spot early signs of the disease years before doctors would find it traditionally on a CT scan, say researchers at Boston’s Mass General Cancer Canter and the Massachusetts Institute of Technology in Cambridge. Sybil accurately predicted lung cancer within a year 86% to 94% of the time in one of their studies.
- Nonsmoking Women and Lung Cancer: What to Know
March 20, 2023 — One in 17 women will be diagnosed with lung cancer in their lifetime. Most women believe that cigarettes are the main risk factor for lung cancer, and many abstain from making smoking a habit. Yet a recent Spanish study reported that female never-smokers are two thirds more likely to develop the disease than men who have never smoked.
